D. Antonio, J. Evans-molina, and C. , Translating the results of randomized trials into clinical practice : the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation, Stroke, vol.37, pp.1075-80, 2006.

C. Landefeld, E. Cook, and M. Flatley, Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy, The American Journal of Medicine, vol.82, issue.4
DOI : 10.1016/0002-9343(87)90004-0

R. Beyth, L. Quinn, and C. Landefeld, Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin ??????Access the ???Journal Club??? discussion of this paper at http://www.elsevier.com/locate/ajmselect/, The American Journal of Medicine, vol.105, issue.2, pp.91-100, 1998.
DOI : 10.1016/S0002-9343(98)00198-3

P. Kuijer, B. Hutten, and M. Prins, Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous Thromboembolism, Archives of Internal Medicine, vol.159, issue.5, pp.457-60, 1999.
DOI : 10.1001/archinte.159.5.457

C. Kearon, J. Ginsberg, and M. Kovacs, Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism, New England Journal of Medicine, vol.349, issue.7, pp.631-640, 2003.
DOI : 10.1056/NEJMoa035422

T. Shireman, J. Mahnken, and P. Howard, Development of a Contemporary Bleeding Risk Model for Elderly Warfarin Recipients, Chest, vol.130, issue.5, pp.1390-1396, 2006.
DOI : 10.1378/chest.130.5.1390

B. Gage, Y. Yan, and P. Milligan, Clinical classification schemes for predicting haemorrhage. Results from the National Registry of Atrial Fibrillation (NRAF)

R. Pisters, D. Lane, and R. Nieuwlaat, A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest, vol.138, issue.5, pp.1093-100, 2010.
DOI : 10.1378/chest.10-0134

M. Fang, A. Go, and Y. Chang, A New Risk Scheme to Predict Warfarin-Associated Hemorrhage, Journal of the American College of Cardiology, vol.58, issue.4
DOI : 10.1016/j.jacc.2011.03.031

K. Dahri and P. Loewen, The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rules, Thrombosis and Haemostasis, vol.98, pp.980-987, 2007.
DOI : 10.1160/TH07-04-0297

G. Pernod, J. Labarère, J. Yver, and B. Satger, EDUC???AVK: Reduction of Oral Anticoagulant-related Adverse Events After Patient Education: A Prospective Multicenter Open Randomized Study, Journal of General Internal Medicine, vol.40, issue.9, pp.1441-1447, 2008.
DOI : 10.1007/s11606-008-0690-1

URL : https://hal.archives-ouvertes.fr/hal-00291806

C. Descamps, B. Jl, P. Couturier, and C. Jc, Evaluation des chutes chez les personnes âgées en médecine ambulatoire. La revue de Gériatrie, pp.302-309, 1995.

G. Pernod, A. Godiér, and C. Gozalo, French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding), 16. HAS. Prise en charge des surdosages en AVK, des situations à risque hémorragique et des accidents hémorragiques chez les patients traités par anti-vitamine K en ville et en milieu hospitalier, pp.167-74, 2008.
DOI : 10.1016/j.thromres.2010.06.017

D. Mcmahan, D. Smith, and M. Carey, Risk of major hemorrhage for outpatients treated with warfarin, Journal of General Internal Medicine, vol.42, issue.suppl, pp.311-317, 1998.
DOI : 10.1046/j.1525-1497.1998.00096.x

S. Connolly, M. Ezekowitz, and S. Yusuf, Dabigatran versus Warfarin in Patients with Atrial Fibrillation, New England Journal of Medicine, vol.361, issue.12, pp.1139-51, 2009.
DOI : 10.1056/NEJMoa0905561

S. Pearson, R. Troughton, and A. Richards, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, vol.365, pp.2334-2339, 2011.

G. Palareti, N. Leali, and S. Coccheri, Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), The Lancet, vol.348, issue.9025, pp.423-431, 1996.
DOI : 10.1016/S0140-6736(96)01109-9

S. Apostolakis, D. Lane, and Y. Guo, Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk???Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation, Journal of the American College of Cardiology, vol.60, issue.9, pp.861-868, 2012.
DOI : 10.1016/j.jacc.2012.06.019

G. Lip, A. Banerjee, and I. Lagrenade, Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project, Circulation: Arrhythmia and Electrophysiology, vol.5, issue.5, pp.941-949, 2012.
DOI : 10.1161/CIRCEP.112.972869

. Société-canadienne-de-cardiologie, Ligne directrice 2010 en matière de fibrillation auriculaire. Consulté en 2013